Revision total hip arthroplasty is associated with significantly higher opioid consumption as compared to primary total hip arthroplasty in the acute postoperative period

被引:5
作者
Bernstein, Jenna A. [1 ]
Feng, James [1 ]
Mahure, Siddharth A. [1 ]
Schwarzkopf, Ran [1 ]
Long, William J. [1 ,2 ]
机构
[1] NYU Langone, Div Orthoped Adult Joint Reconstruct, New York, NY USA
[2] Insall Scott Kelly Inst, 260 East 66th St, New York, NY 10065 USA
关键词
Opioid use; postoperative pain; revision total hip; MULTIMODAL PAIN MANAGEMENT; RISK-FACTORS;
D O I
10.1177/1120700020938324
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: There are currently a lack of investigations that characterised narcotic utilisation following revision total hip arthroplasty (THA). We sought to determine if immediate post-surgical opioid use was different between revision THA and primary THA. Methods: A single institution total joint arthroplasty database was used to identify adult patients who underwent revision THA or primary THA from 2016 to 2019. Morphine milligram equivalents (MME) were calculated for different time periods. Results: 6977 patients were identified, 89.72% primary THA and 10.28% revision THA. Aggregate opioid consumption was higher for revision THA patients (317.40 MME vs. 93.01 MME), as was opioid consumption in the first 24 hour and second 24-hour periods. Visual analogue pain (VAS) scores were significantly higher in the 0-12 hour postoperative and the 12-24 hours postoperative periods in the revision THA group. Conclusions: Patients undergoing revision THA had significantly higher narcotic utilisation than those undergoing primary THA, particularly in the first 24 hours postoperatively.
引用
收藏
页码:59 / 63
页数:5
相关论文
共 32 条
  • [1] Does Preoperative Opioid Use Increase the Risk of Early Revision Total Hip Arthroplasty?
    Bedard, Nicholas A.
    DeMik, David E.
    Dowdle, S. Blake
    Owens, Jessell M.
    Liu, Steve S.
    Callaghan, John J.
    [J]. JOURNAL OF ARTHROPLASTY, 2018, 33 (07) : S154 - S156
  • [2] Canata Gian Luigi, 2016, Joints, V4, P222, DOI 10.11138/jts/2016.4.4.222
  • [3] Centers for Disease Control and Prevention, 2018, OP OR MORPH MILL EQ
  • [4] Distribution of Opioids by Different Types of Medicare Prescribers
    Chen, Jonathan H.
    Humphreys, Keith
    Shah, Nigam H.
    Lembke, Anna
    [J]. JAMA INTERNAL MEDICINE, 2016, 176 (02) : 259 - 261
  • [5] Does Dexamethasone Reduce Hospital Readiness for Discharge, Pain, Nausea, and Early Patient Satisfaction in Hip and Knee Arthroplasty? A Randomized, Controlled Trial
    Dissanayake, Ravi
    Du, Hao Nan
    Robertson, Lain K.
    Ogden, Kathryn
    Wiltshire, Kaitlyn
    Mulford, Jonathan S.
    [J]. JOURNAL OF ARTHROPLASTY, 2018, 33 (11) : 3429 - 3436
  • [6] Duellman Todd J, 2009, Orthopedics, V32, P167
  • [7] Feng J, 2019, 2019 AAHKS ANN M NOV
  • [8] Gabriel Rodney A, 2018, Anesthesiol Clin, V36, P387, DOI 10.1016/j.anclin.2018.05.002
  • [9] Poorly controlled postoperative pain: prevalence, consequences, and prevention
    Gan, Tong J.
    [J]. JOURNAL OF PAIN RESEARCH, 2017, 10 : 2287 - 2298
  • [10] Risk factors for persistent and new chronic opioid use in patients undergoing total hip arthroplasty: a retrospective cohort study
    Inacio, Maria C. S.
    Hansen, Craig
    Pratt, Nicole L.
    Graves, Stephen E.
    Roughead, Elizabeth E.
    [J]. BMJ OPEN, 2016, 6 (04):